Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesBariatric & Obesity ManagementBlue Cross Blue Shield RI SADI-S Coverage & PA | O…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

    Bariatric Surgery — SADI-S and Other Procedures Coverage Criteria

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts

    Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, coverage stance, and prior authorization requirements for single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) and lists bariatric procedures considered not covered or not medically necessary for Medicare Advantage and Commercial products.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyBariatric Surgery — SADI-S and Other Procedures Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Last ReviewMar 18, 2026
    Next Review DateMar 18, 2026
    Key ActionObtain prior authorization for SADI-S for Medicare Advantage and verify member benefits and eligibility with BCBSRI before scheduling.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ≥40 or 30–39.9 w/ T2DMBMI thresholds
    Ages 13+ / 18+Age eligibility
    Required (MA)PA requirement
    Medicare-only listMedicare not-covered list
    Use unlisted CPTNo specific SADI-S code
    113References

    Coverage and Medical Necessity

    SADI-S Revision Criteria

    Revision procedures considered medically necessary when specific complications or failure are present:

    Revision for complications or failure: Revision surgery to address perioperative or late complications of the SADI-S procedure (examples include staple line failure, obstruction, stricture, nonabsorption resulting in hypoglycemia or malnutrition, weight loss ≥20% below ideal body weight, and band slippage not correctable with manipulation/adjustment) is medically necessary.

    Revision for gastric pouch dilation is medically necessary if the initial procedure produced weight loss prior to dilation and the individual was compliant with prescribed nutrition and exercise; revision for severe reflux refractory to medical treatment is also medically necessary.

    Bariatric surgery for BMI <35 kg/m2

    Bariatric surgery in patients with BMI <35 kg/m2

    Investigational for BMI <35: Bariatric surgery for patients with BMI less than 35 kg/m2 is considered investigational due to limited evidence and lack of support in current specialty society guidelines; while case series report diabetes remission after gastric bypass, this is not standard of care.BMI <35 kg/m2

    Insufficient evidence to demonstrate improved health outcomes in patients without diabetes; not standard practice.

    Laparoscopic gastric plication

    Laparoscopic gastric plication

    Insufficient evidence: Evidence is limited and comparative trials (especially RCTs) are scarce; systematic review data show sleeve gastrectomy superior through 24 months and long-term outcomes are uncertain.N/A

    Technique is not standardized; evidence insufficient to determine net health outcome.

    Endoscopic revision devices (e.g., StomaphyX, suturing devices)

    Endoscopic revisional procedures and devices

    Limited/insufficient evidence: Published data are largely case series and small trials; randomized or comparative trials are generally lacking or inconclusive and durability and efficacy remain concerns.N/A

    Some devices (e.g., StomaphyX) had 510(k) clearance, but RCTs failed to meet primary endpoints or were stopped early; most devices are no longer commercially available.

    Intragastric balloons

    Intragastric balloons

    Short-term efficacy; safety concerns: RCTs show superior short-term weight loss compared with sham or lifestyle therapy, but long-term weight regain is common; there have been serious adverse events and multiple deaths reported prompting FDA safety communications.N/A

    Providers are encouraged to monitor patients closely due to safety signals and need for additional long-term data.

    Aspiration therapy

    Aspiration therapy

    Limited evidence and device issues: RCT data show greater weight loss at 1 year compared with lifestyle therapy, but long-term follow-up is limited with high attrition; device-related adverse events and maintenance needs (A-tube replacement expected in ~50% by ~3.5 years) affect outcomes.N/A

    Insufficient evidence to conclude long-term net health benefit.

    Preadolescent bariatric surgery

    Preadolescent bariatric surgery

    Insufficient evidence: No studies focused solely on preadolescent children; some cohort and registry analyses suggest safety and efficacy at specialized centers, but comparative studies are lacking.preadolescent age group

    Further research is required before routine use in preadolescents can be recommended.

    Other procedures (biliopancreatic bypass, etc.)

    Other bariatric procedures

    Insufficient evidence: Evidence is insufficient to draw conclusions on biliopancreatic bypass and other less common procedures; some data suggest greater weight loss but higher rates of complications and nutritional risk.N/A

    Insufficient data to determine net health outcomes; careful consideration of complication and nutritional risk is required.

    The policy identifies certain bariatric procedures that are considered not covered for Medicare Advantage or not medically necessary for Commercial Products when the applicable medical criteria are not met. For Medicare Advantage Plans, examples include open adjustable gastric banding, open sleeve gastrectomy, open and laparoscopic vertical banding gastroplasty, gastric balloon for treatment of obesity, and intestinal bypass. For Commercial Products, procedures designated as not medically necessary include vertical-banded gastroplasty, mini-gastric bypass (Billroth II type), biliopancreatic bypass without duodenal switch, and long-limb gastric bypass (>150 cm). Additionally, a subset of endoscopic procedures is listed as not medically necessary for Commercial Products (see related blocks).

    The SADI-S procedure for preadolescent individuals (<13 years) with obesity is explicitly stated as not covered for Medicare Advantage Plans and not medically necessary for Commercial Products due to insufficient evidence to determine health outcomes in this age group.

    For Medicare Advantage Plans only, and consistent with Centers for Medicare & Medicaid Services determinations, the policy lists specific open procedures as not covered because evidence is insufficient to determine net health benefit. These include open adjustable gastric banding, open sleeve gastrectomy, open and laparoscopic vertical banding gastroplasty, gastric balloon for treatment of obesity, and intestinal bypass.

    Services determined to be not medically necessary or otherwise non-covered benefits are excluded from payment and may be denied. Providers should verify member-specific benefits and eligibility with the provider call center because subscriber agreements and employer contracts supersede this policy.

    The policy specifically lists several endoscopic procedures as not medically necessary when used as primary bariatric procedures or as revisional treatments for weight regain. These include insertion of the StomaphyX™ device, endoscopic gastroplasty, endoscopically placed duodenojejunal sleeve, intragastric balloons, aspiration therapy devices, and esophagogastroduodenoscopy with volume adjustment of an intragastric bariatric balloon.

    The policy identifies specific CPT codes that are not covered for Medicare Advantage Plans and/or not medically necessary for Commercial Products in certain contexts. Examples called out include 43290, 43842, 43843 (not covered/not medically necessary) and 43847 when used for long-limb gastric bypass (>150 cm) for Commercial Products. Unlisted procedure codes are referenced for filing procedures lacking specific CPT codes.

    If services are determined to be not medically necessary or are non-covered benefits, providers may not charge the member unless the member provided prior written agreement in advance to pay out-of-pocket. Failure to follow this requirement may result in denials and is governed by participation agreements and subscriber/employer contracts.

    Coding and Definitions

    Referenced CPT codesCPT
    43847Long-limb Roux-en-Y gastroenterostomy (gastric bypass) — referenced in policy for PA and procedure description
    43846Roux-en-Y gastroenterostomy (short limb) — noted as distinct from mini-gastric bypass and long-limb procedures
    43843Gastric restrictive procedure, without gastric bypass; other than vertical-banded gastroplasty (used for laparoscopic gastric plication)
    Coding guidance and not-covered codesmixed
    43659Unlisted laparoscopy procedure, stomach
    43999Unlisted procedure, stomach
    44799Unlisted procedure, small intestine
    44238Unlisted laparoscopy procedure, intestine (except rectum)
    43848Revision, open, of gastric restrictive procedure for morbid obesity, other than adjustable gastric restrictive device (separate procedure)
    43290Esophagogastroduodenoscopy, flexible, transoral; with deployment of intragastric bariatric balloon
    43842Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty
    43843Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical-banded gastroplasty
    43847Gastric restrictive procedure, with gastric bypass for morbid obesity; with small intestine reconstruction to limit absorption
    S2083Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline (HCPCS) - not separately reimbursed
    Commercial Products — code flagged not medically necessary for long-limb gastric bypass (>150 cm)CPTNot Covered
    43847Gastric restrictive procedure, with gastric bypass for morbid obesity; with small intestine reconstruction to limit absorption
    inv-20: BMI — eligibility thresholds
    Eligibility BMI thresholdsMembers must have ONE of: BMI ≥40 kg/m2; OR BMI 30–34.9 kg/m2 or 35–39.9 kg/m2 combined with Type 2 Diabetes (T2DM)
    Conservative therapy requirementFailed weight loss with conservative measures including documented participation in a formal weight reduction program (weight, diet, exercise)
    Age considerationsMay be considered for adults (≥18 years) and adolescents (13 to <18 years) with greater psychosocial/informed-consent considerations for adolescents
    inv-21: long-limb gastric bypass length — >150 cm
    Long-limb definition>150 cm alimentary/common limb length (Roux-en-Y variations described with alimentary and common limb length differences)

    Provider Steps, Authorization, and Documentation

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for Medicare Advantage Plans and is recommended for Commercial Products for Single Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy (SADI-S). Prior authorization is required for Medicare Advantage Plans and is recommended for Commercial Products for CPT code 43847. Providers should confirm member-specific coverage, eligibility, and prior authorization requirements by contacting the BCBSRI provider call center before scheduling services.

    • Prior authorization required for Medicare Advantage Plans for SADI-S and for CPT 43847
    • Prior authorization recommended for Commercial Products for SADI-S and CPT 43847
    • Contact BCBSRI provider call center to verify member benefits and obtain prior authorization details
    Billing Rule

    Clinical and Evidence Context

    Bariatric surgery is a treatment for obesity reserved for patients who have failed conservative measures; techniques reduce caloric intake or absorption and may have metabolic effects. SADI-S combines sleeve gastrectomy with a single anastomosis duodeno-ileal bypass and has been evaluated as an alternative to Roux-en-Y, with randomized data demonstrating greater percentage excess weight loss at 2 years in a trial of 381 patients, while overall safety profiles were comparable. Overall, selection of surgical approach depends on patient factors, prior treatments, and evidence supporting long-term outcomes.

    Procedure Definitions

    inv-34: SADI-S — definition of single anastomosis duodeno-ileal bypass with sleeve gastrectomy
    DefinitionSingle anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) combines a sleeve gastrectomy with a single duodeno-ileal anastomosis as an alternative to Roux-en-Y gastric bypass
    Clinical contextProposed since 2007 as an alternative to RYGB; randomized data (381 patients) showed superior %EWL at 2 years for SADI-S versus RYGB with similar safety profile
    Coding noteNo specific CPT code exists for SADI-S; report with appropriate unlisted procedure codes as indicated
    inv-35: Long-limb gastric bypass (>150 cm) — definition and clinical note
    DefinitionLong-limb Roux-en-Y gastric bypass (>150 cm): variation with alimentary and common limb lengths >150 cm creating combined restrictive and malabsorptive effects
    Clinical note
    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyBariatric Surgery — SADI-S and Other Procedures Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Last ReviewMar 18, 2026
    Next Review DateMar 18, 2026
    Key ActionObtain prior authorization for SADI-S for Medicare Advantage and verify member benefits and eligibility with BCBSRI before scheduling.
    SourceLink
    On This Page
    Coverage and Medical NecessityCoding and DefinitionsProvider Steps, Authorization, and DocumentationClinical and Evidence ContextProcedure Definitions
    CPT guidance (Commercial)
    Use of CPT code 43847 for procedures described as long-limb (>150 cm) is designated not medically necessary for Commercial Products
    Physiologic effectLong-limb Roux-en-Y combines restrictive gastric pouch with malabsorptive effects dependent on anastomosis location

    Use of Unlisted CPT Codes for SADI-S and Other Unlisted Procedures

    There is no specific CPT code for the SADI-S procedure. Claims should be filed using an appropriate unlisted CPT code when no specific code exists. Use one of the following as applicable: 43659, 43999, or 44799. When filing unlisted procedure codes, include sufficient operative documentation and rationale for code selection to support medical necessity and to facilitate claim review.

    • Use 43659, 43999, or 44799 for SADI-S when no specific CPT exists
    • Include detailed operative report and justification when submitting unlisted CPT codes
    Note

    Coverage Dependent on Meeting Criteria

    Coverage for SADI-S is dependent on meeting the published medical necessity criteria. The procedure is considered medically necessary only when all required criteria (e.g., BMI thresholds, failed conservative measures, tobacco/substance-free intervals, psychosocial and dietary evaluations, pregnancy considerations, and surgeon/institutional qualifications) are documented. SADI-S is not covered for Medicare Advantage Plans and is not medically necessary for Commercial Products when the medical criteria are not met.

    • Procedure considered medically necessary only when ALL policy criteria are met (see medical criteria list)
    • Not covered/not medically necessary if documentation does not meet criteria
    Documentation Required

    Required Documentation to Support Medical Necessity

    Providers must submit documentation to support medical necessity with prior authorization and with claims. Required documentation includes, but is not limited to: thorough weight history and BMI calculations, records of failed conservative measures including participation in a formal weight reduction program with documented weight, diet, and exercise, psychosocial evaluation and clearance, dietary consultation notes, tobacco-free and substance/alcohol-free documentation with specified durations, informed consent discussion, and surgeon/institutional credentials or program participation.

    • Document BMI and qualifying obesity class and/or presence of type 2 diabetes when applicable
    • Provide records of formal weight reduction program participation and outcomes
    • Include psychosocial evaluation and behavioral health clearance
    • Document tobacco-free ≥ 6 weeks and substance/alcohol-free ≥ 1 year where applicable
    • Include dietary consultation and informed consent documentation
    • Provide surgeon training/experience and evidence of comprehensive bariatric program
    Documentation Required

    EGD Documentation That Changes Surgical Planning

    Esophagogastroduodenoscopy (EGD) findings that alter operative management or postpone surgery should be clearly documented and submitted. While routine preoperative EGD may not change management in the majority of patients, if EGD identifies conditions that contraindicate or change the planned bariatric procedure (e.g., malignancy, large hiatal hernia, peptic ulcer, H. pylori), include the EGD report and explanation of how findings affected surgical planning.

    • Attach EGD report when findings change surgical plan or delay surgery
    • Specify how EGD findings impacted the choice or timing of procedure
    Step Therapy

    No Specified Step Therapy

    No specific step therapy sequence is required by this policy. However, the policy emphasizes that members must have failed conservative measures including participation in a formal weight reduction program prior to qualifying for SADI-S.

    • No explicit step therapy requirements stated
    • Conservative therapy failure (formal weight reduction program) is required
    Denial Risk

    Claims Using Specific CPT/HCPCS Codes Will Be Denied for Certain Benefit Types

    Claims submitted using CPT/HCPCS codes listed as not covered or not separately reimbursed will be denied for the applicable Medicare Advantage benefit types, and may be denied for Commercial Products when not medically necessary. The following CPT codes are listed as not covered/not medically necessary and will be denied if used for the excluded indications: 43290, 43842, 43843, 43847 (when used for long-limb gastric bypass >150 cm for Commercial Products listed as not medically necessary). The HCPCS code S2083 is not separately reimbursed. Providers should not bill members for services denied as not medically necessary or non-covered except where allowed and documented in advance per participation agreements.

    • Not covered / not medically necessary CPTs: 43290, 43842, 43843
    • 43847: not medically necessary for long-limb gastric bypass (>150 cm) for Commercial Products
    • HCPCS S2083 is not separately reimbursed
    • Providers may not bill members for denied/non-covered services unless prior written agreement exists
    Long alimentary limb permits more nutrient absorption while a short common limb limits fat absorption; when CPT 43847 is used for >150 cm limb, Commercial Products may deem it not medically necessary
    Coding distinctionCPT 43846 describes short-limb (<150 cm) Roux-en-Y and does not apply to long-limb procedures
    inv-36: Laparoscopic gastric plication — definition
    DefinitionLaparoscopic gastric plication: laparoscopic placement of sutures along the greater curvature or anterior stomach to create a tube-like stomach (mobilization of greater curvature and suture plication for gastric restriction)
    Technique variabilityTechnique specifics are not standardized (greater curvature plication or anterior curvature plication)
    Evidence noteComparative studies are limited; systematic review shows sleeve gastrectomy superior through 24 months; long-term outcomes uncertain
    inv-37: Intragastric balloon (IGB) — definition and brief evidence note
    DefinitionIntragastric balloon (IGB): a temporary endoluminal device placed in the stomach to induce weight loss
    Evidence noteRandomized trials show greater short-term weight loss versus sham or lifestyle therapy; long-term regain is common and adverse events including deaths prompted FDA safety communications
    Safety monitoringProviders are encouraged to monitor patients closely due to reported serious adverse events and FDA warnings (spontaneous inflation, pancreatitis, reported deaths)
    inv-38: Aspiration therapy (AT) — definition and brief evidence note
    DefinitionAspiration therapy (AT): treatment using a gastrostomy port and external device (A-tube) that allows aspiration of gastric contents to reduce caloric absorption
    Evidence noteRCT data show greater weight loss at 1 year versus lifestyle therapy, but long-term follow-up is limited with high attrition and device-related adverse events (A-tube replacement commonly needed ~3.5 years)
    Uncertain long-term benefitLimited data and maintenance/replacement needs affect conclusions about long-term net health benefit